Logan University Health Centers and Arete Healthcare Partner to Expand Patient Access and Modernize Clinical Care Logan University Health Centers has announced a strategic partnership with Arete Healthcare aimed at expanding access to healthcare, improving clinical operations, and creating stronger…
New Study in Neurology Highlights the Potential of Quantitative MRI Biomarkers for Assessing Muscle Changes in SBMA AMRA Medical has announced the publication of new research in Neurology demonstrating the potential of quantitative whole-body magnetic resonance imaging (MRI) to measure…
Lōkahi Therapeutics Begins GMP Manufacturing of LT-100 for Potential Osteoarthritis Pain Treatment Lōkahi Therapeutics Inc., a subsidiary of Glucotrack, Inc. (NASDAQ: GCTK), has announced the initiation of its initial Good Manufacturing Practice (GMP) manufacturing campaign for LT-100, a pure honeybee…
Ivonescimab Plus Chemotherapy Phase III HARMONi Results Published in The Lancet Oncology Summit Therapeutics Inc. has announced the publication of primary analysis results from its global Phase III HARMONi clinical trial in The Lancet Oncology, providing peer-reviewed evidence supporting the…
Copia Scientific and HSE•AG Partner to Expand On-Deck Nucleic Acid Quantification for Laboratory Automation Copia Scientific, a provider of laboratory automation, equipment, integration and technical service solutions, has announced a new distribution agreement with HSE•AG, a Switzerland-based developer and manufacturer…
Spruce Biosciences Advances Toward 2026 BLA Submission for Tralesinidase Alfa in Sanfilippo Syndrome Type B Spruce Biosciences, Inc., a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies for neurological disorders with significant unmet medical needs, has announced important…
TwinStrand Biosciences Secures More Than $245 Million Judgment in Patent Infringement Case Against Guardant Health TwinStrand Biosciences, Inc., the developer of Duplex Sequencing® technology, announced that the U.S. District Court for the District of Delaware entered a final judgment on…
AbbVie Highlights New Lung Cancer Research Data Across NSCLC and SCLC Programs at WCLC 2026 AbbVie is showcasing a broad collection of new research findings across its lung cancer development portfolio at the 2026 World Conference on Lung Cancer (WCLC),…
Integrated DNA Technologies Expands DNA Synthesis Capabilities to Support Genomics Programs Across Scale and Complexity Integrated DNA Technologies (IDT), a Danaher company and global provider of genomics solutions, has announced an expansion of its DNA synthesis capabilities designed to address…
BioTalent Canada and Montréal InVivo Strengthen Partnership to Expand Life Sciences Workforce Development BioTalent Canada and Montréal InVivo have announced an expanded partnership designed to strengthen workforce development across Canada’s life sciences and health technology (LSHT) sector. As part of…
bioAffinity Technologies Expands Government Healthcare Reach Through Distribution Agreement with AvMEDICAL for CyPath Lung bioAffinity Technologies, Inc., a biotechnology company focused on developing noninvasive diagnostic solutions for the early detection of lung cancer and other pulmonary diseases, has announced a…
Ingenia Therapeutics Begins KOSDAQ Trading to Advance Vascular-Targeted Therapy Pipeline Ingenia Therapeutics, a clinical-stage biotechnology company focused on developing next-generation vascular-targeted therapies, has announced that its shares have begun trading on South Korea’s KOSDAQ market, marking a significant milestone in…